200 related articles for article (PubMed ID: 31429764)
1. Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213.
Kuo YY; Huo C; Lin CY; Lin HP; Liu JS; Wang WC; Chang CR; Chuu CP
Cell Commun Signal; 2019 Aug; 17(1):100. PubMed ID: 31429764
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT.
Kuo YY; Huo C; Li CY; Chuu CP
Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38480977
[TBL] [Abstract][Full Text] [Related]
3. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.
Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP
Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells.
Tseng JC; Wang BJ; Wang YP; Kuo YY; Chen JK; Hour TC; Kuo LK; Hsiao PJ; Yeh CC; Kao CL; Shih LJ; Chuu CP
Phytomedicine; 2023 Jul; 116():154860. PubMed ID: 37201366
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference.
Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP
J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester attenuates lipopolysaccharide-stimulated proinflammatory responses in human gingival fibroblasts via NF-κB and PI3K/Akt signaling pathway.
Li L; Sun W; Wu T; Lu R; Shi B
Eur J Pharmacol; 2017 Jan; 794():61-68. PubMed ID: 27832944
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.
Chuu CP; Lin HP; Ciaccio MF; Kokontis JM; Hause RJ; Hiipakka RA; Liao S; Jones RB
Cancer Prev Res (Phila); 2012 May; 5(5):788-97. PubMed ID: 22562408
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling.
Kuo YY; Lin HP; Huo C; Su LC; Yang J; Hsiao PH; Chiang HC; Chung CJ; Wang HD; Chang JY; Chen YW; Chuu CP
Int J Mol Sci; 2013 Apr; 14(5):8801-17. PubMed ID: 23615471
[TBL] [Abstract][Full Text] [Related]
10. Anti-COVID-19 Potential of Withaferin-A and Caffeic Acid Phenethyl Ester.
Kumar V; Sari AN; Gupta D; Ishida Y; Terao K; Kaul SC; Vrati S; Sundar D; Wadhwa R
Curr Top Med Chem; 2024; 24(9):830-842. PubMed ID: 38279743
[TBL] [Abstract][Full Text] [Related]
11. Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy.
Chang H; Wang Y; Yin X; Liu X; Xuan H
BMC Complement Altern Med; 2017 Sep; 17(1):471. PubMed ID: 28950845
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
13. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester induces radiosensitization via inhibition of DNA damage repair in androgen-independent prostate cancer cells.
Anjaly K; Tiku AB
Environ Toxicol; 2022 May; 37(5):995-1006. PubMed ID: 35006630
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation.
Kim H; Kim W; Yum S; Hong S; Oh JE; Lee JW; Kwak MK; Park EJ; Na DH; Jung Y
Free Radic Biol Med; 2013 Dec; 65():552-562. PubMed ID: 23892357
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer.
McAllister MJ; McCall P; Dickson A; Underwood MA; Andersen D; Holmes E; Markert E; Leung HY; Edwards J
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):596-606. PubMed ID: 32358577
[TBL] [Abstract][Full Text] [Related]
17. Caffeic acid phenethyl ester inhibits nuclear factor-kappaB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells.
Wang LC; Chu KH; Liang YC; Lin YL; Chiang BL
Clin Exp Immunol; 2010 May; 160(2):223-32. PubMed ID: 20059479
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester guards against benign prostate hypertrophy in rats: Role of IGF-1R/protein kinase-B (Akt)/β-catenin signaling.
Omar HA; Tolba MF
IUBMB Life; 2018 Jun; 70(6):519-528. PubMed ID: 29603556
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid phenethyl ester inhibits the progression of ovarian cancer by regulating NF-?B signaling.
Liu GL; Han NZ; Liu SS
Biomed Pharmacother; 2018 Mar; 99():825-831. PubMed ID: 29710481
[TBL] [Abstract][Full Text] [Related]
20. Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
Shigeoka Y; Igishi T; Matsumoto S; Nakanishi H; Kodani M; Yasuda K; Hitsuda Y; Shimizu E
J Cancer Res Clin Oncol; 2004 Mar; 130(3):146-52. PubMed ID: 14691717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
